Body Fat Reduction Market Forecast Growth Report | Size & Share Outlook 2031

[Research Report] The body fat reduction market size is projected to grow from US$ 8,452 million in 2022 to US$ 16462.76 million by 2031; it is estimated to record a CAGR of 8.70% during 2022-2031.

Market Insights and Analyst View:

The reduction of stored body fat is called fat reduction. Fat reduction and weight reduction are different. Fat reduction is focused exclusively on losing the fat content in the body. Losing fat enhances fitness levels and strength and improves work performance in daily life. The different fat reduction procedures include Abdominoplasty, Liposuction, Radiofrequency, Ultrasound, Cryolipolysis, and Mesotherapy.

Factors that positively affect the body fat reduction market are the growing prevalence of obesity across the globe, which boosts the need for body fat reduction. Also, the rising customer preference for noninvasive procedures, the growing favorable government policies, and programs for obesity reduction are driving investment in the body fat reduction market.

Growth Drivers:

Excess amount of fat accumulation in the body is known as obesity, which can cause various health problems. When the body mass index is 25 or above, it is considered obesity. Obesity is one of the leading causes of various health conditions, such as cardiovascular disorders and diabetes. Changes in food habits and sedentary lifestyles have increased the prevalence of obesity on a global level. A large percentage of the population consuming high-calorie, high-fat food with limited physical activity has increased obesity rates. According to the World Health Organization, in 2022, ~1 billion people worldwide were obese, including 39 million children, 340 million adolescents, and 650 million adults. There are various factors, such as genetic, behavioral, metabolic, and hormonal, that influence body weight and can cause obesity.

In some cases, obesity can be caused due to medical reasons such as hypothyroidism, Cushing syndrome, and Prader-Willi syndrome. The increasing prevalence of obesity leads to various health concerns. Most of the obese population experience depression, shame, and guilt about their social isolation, disability, and lower work achievement, which affects their quality of life. According to the National Council of Aging (NCOA) 2021 report, adults with excess weight had a 55% higher risk of developing depression in their lifetime than those who did not suffer from obesity.

To overcome the abovementioned conditions and increase awareness among large populations about the consequences of obesity, the demand for body fat reduction is increasing as it helps in weight reduction. According to The Aesthetic Society, the fat reduction procedure count was 217,277 and 137,119 in 2021 and 2021, respectively. Furthermore, 491,098 Liposuction procedures and 242,939 Abdominoplasty (Tummy Tuck) procedures were carried out in 2021. Therefore, the increasing prevalence of obesity and rising awareness about its consequences have increased the demand for body fat reduction procedures, driving the body fat reduction market.  

Strategic Insights

Report Segmentation and Scope:

The “Body Fat Reduction Market” is segmented on the basis of procedure, gender, service provider, and geography. Based on procedure, the market is segmented into surgical and non-surgical. The surgical segment is bifurcated as liposuction and abdominoplasty. The non-surgical segment is further subsegmented as cryolipolysis, ultrasound, and others. In terms of gender, the body fat reduction market is segmented into female and male. Based on the service provider, the market is categorized into hospitals & clinics, medical spas, and others. The body fat reduction market, based on geography is segmented into North America (US, Canada, and Mexico), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

Segmental Analysis:

The body fat reduction market based on the procedure is bifurcated as surgical and non-surgical. The surgical segment is bifurcated as liposuction and abdominoplasty. The surgical segment is further subsegmented as cryolipolysis, ultrasound, and others.

The surgical segment held the largest share of the market in 2022 and is estimated to register the highest CAGR in the market during 2022-2031. According to the American Society of Plastic Surgeons (ASPS), liposuction targeting those obstinate fat deposits topped the list of cosmetic procedures in 2022. With a staggering 325,669 procedures performed, it marked an impressive 23% growth since 2021. Close on its heels at number 3, abdominoplasty not only flattened a significant number of abdomens but also witnessed a 37% growth since the pre-pandemic days, with 161,948 procedures performed in 2022. 

Liposuction holds the top spot for the second release in a row. Liposuction sculpts the body by reducing excess fat from specific areas, including the thighs, butt, abdomen, hips, arms, back, or neck, to enhance contouring, creating a more proportionate appearance. Liposuction removes stubborn, unwanted fat that diet and exercise can’t eliminate. With new product launches and the increase in number of liposuction, the liposuction segment is expected to hold a significant share of the body fat reduction market.

Body Fat Reduction Market by Gender – 2022 and 2031

Based on gender, the body fat reduction market is segmented into female and male. The female segment held the largest market share in 2022 and is anticipated to grow at the fastest rate during 2022-2031. Women have more body fat than men because of many different reasons. One is biological. For women of average size, a body fat content of 25%  compared to men have 15%. Though all other things being equal, such as exercise levels and age, women need fewer calories per kilogram of body weight daily than men. According to the Aesthetic Society, 458,628 Liposuction and 234,696 Abdominoplasty (Tummy Tuck) were carried out in women in 2021. According to the International Society of Aesthetic Plastic Surgery, 605,669 non-surgical fat reduction procedures were carried out in women, and 125,311 non-surgical fat reduction procedures were carried out in men. The female segment is likely to experience growth due to an increasing fat percentage in women yearly and growing awareness about the aesthetic appearance of body images.

Based on the service provider, the body fat reduction market is segmented into hospitals & clinics, medical spas, and others. The hospitals & clinics segment held the largest market share in 2022. However, the medical spas segment is anticipated to register the highest CAGR during 2022-2031. In hospitals, various body fat reduction surgeries are performed on people suffering from obesity. Hospitals perform fat reduction designed for each patient based on weight and health condition. In addition to the surgical process, hospitals strongly emphasize patient counseling, dietary management, and regular follow-up to address all weight-related issues. Cosmetic treatments are known to have a significant impact on the confidence and self-image of the people seeking those treatments, and this factor will continue to boost the popularity of various body fat reduction procedures, such as liposuction and abdominoplasty, in the coming years. Moreover, the procedures can easily be performed in the clinics If only a tiny amount of fat is to be removed. Thus, the abovementioned factors are likely to drive the growth of the segment during the forecast period.

Regional Analysis:

Based on geography, the body fat reduction market is divided into five key regions: North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa. North America is likely to capture a significant share of the global market in 2022. The market growth in the region is attributed to the rising prevalence of obesity, technological advancement in new product development for fat reduction, and the number of facilities offering body contouring services. In addition, a growing number of market players are expanding their geographical footprint in North American countries.

Demand for body fat reduction surgeries has increased remarkably over the past few years to reduce the burden associated with a wide range of chronic diseases. According to World Obesity Atlas 2022, the estimated number of adults with BMI ≥30kg/m2 in the US for women and men by 2031 is as follows:     

ADULT OBESITY IN 2031

		BMI ≥30	BMI ≥35	BMI ≥40
MEN	Prevalence (%)	46.58%	21.81%	9.01%
	Total number	61,100,720	28,607,253	11,824,823
WOMEN	Prevalence (%)	47.13%	27.58%	13.89%
	Total number	64,414,854	37,699,103	18,990,994

Thus, populations with high BMIs in the US are more likely to have body fat reduction surgeries to avoid complications associated with diabetes and heart diseases, as well as improve body image and aesthetic appearance.

Canada is among the countries that conduct extensive scientific research in all the fields of healthcare and medical science. The country has a rich history of groundbreaking innovations in medical technologies. The refinement and development of novel technologies is a leading factor in a delivery strategy that further impacts the treatment of chronic diseases such as obesity, diabetes, and cardiovascular diseases. 

The prevalence of obesity in Canada also boosted the body fat reduction surgeries market growth. According to World Obesity Atlas 2022, the estimated number of adults with BMI ≥30kg/m2 in Canada for women and men by 2031 is as follows:

ADULT OBESITY IN 2031

		BMI ≥30	BMI ≥35	BMI ≥40
MEN	Prevalence (%)	38.94	14.77	4.54
	Total number	6,264,762	2,375,821	730,728
WOMEN	Prevalence (%)	37.99	18.58	7.68
	Total number	6,271,328	3,067,467	1,268,361

According to data published by The National Center for Biotechnology Information in December 2017, it is projected that by 2050, the percentage of obese men and women will rise to 54% and 37% in Mexico, respectively, and more people will be obese than overweight. Obesity also contributes to sleep disorders, dyslipidemia, type 2 diabetes, and cardiovascular risk factors, hypertension. Body fat reduction helps reduce the risks mentioned above and improves the aesthetic appearance of people; thus, there is a high demand for body fat reduction in Mexico.      

Industry Developments and Future Opportunities:

Various initiatives taken by key players operating in the global body fat reduction market are listed below:

1. In July 2022, Herbalife Nutrition introduced its latest science-backed product, Litramine, Fat Release, to support its consumers' healthy and active lifestyles. The product helps trim the fat from food by keeping consumers on track with their health goals.
2. In January 2021, Allergan Aesthetics, an AbbVie company, launched a product, CoolSculpting Elite, an advanced fat reduction system with applicators designed to complement the natural curves of the body. CoolSculpting Elite utilizes proven CoolSculpting technology to target, freeze, and eliminate treated fat cells. CoolSculpting Elite is FDA-cleared for the treatment of visible fat bulges in 9 body areas, including the abdomen, thigh, and flank, along with bra fat, underneath the buttocks, back fat, upper arm, and the submental and submandibular areas,
3. In October 2022, Renew ND launched EON treatment that uses autonomous robotic technology, a first of its kind in Washington state. The treatment will enable the company to offer their patients a noninvasive body contouring treatment that permanently eliminates fat cells without the downtime of a surgical procedure. EON treatments give high patient satisfaction and are outstanding for patients trying to target those fat from stubborn areas that exercise and diet cannot enhance.
4. In April 2022, Dominion Aesthetic Technologies, Inc. announced EON Smarter Body Contouring, used for noninvasive laser lipolysis of adipose tissue, has received FDA clearance for the flanks. The clearance is the second clearance for EON from launching in February 2021. EON was previously FDA-cleared as a 510 K device for a full abdomen and is in use for permanent reduction of fat in over 18 states by Dermatologists, Plastic Surgeons, and Medical Spas.
5. In July 2021, Hologic's Cynosure Division Expanded its Body Contouring Portfolio with TempSure Firm for Tissue Heating and Cellulite Treatments and SculpSure Petite Mask for Submental Fat Reduction.     

Competitive Landscape and Key Companies:

AbbVie Inc., Apollo Hospitals Enterprise Limited, Bausch Health Companies Inc., Candela Medical, Cutera Inc., VLCC Health Care Ltd., Cynosure, Llc., Lumenis, Ltd., Sciton, Inc., Sisram Medical Ltd are the major body fat reduction companies. These companies focus on new technologies, advancements in existing products, and geographic expansions to meet the growing consumer demand worldwide.    

REGIONAL FRAMEWORK

Body Fat Reduction Market Report Analysis

MARKET PLAYERS

Body Fat Reduction Market Report Scope